Reply to A. Piccardo et al, E. Hindié et al, M.C. Kreissl et al, M. Doss, J. Buscombe, R. Fisher, M. Sollini et al, M. Lichtenstein, and M. Tulchinsky et al-Reference-Cited by-同舟云学术

Reply to A. Piccardo et al, E. Hindié et al, M.C. Kreissl et al, M. Doss, J. Buscombe, R. Fisher, M. Sollini et al, M. Lichtenstein, and M. Tulchinsky et al

Published:2018-06-20 Issue:18 Volume:36 Page:1889-1892
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Molenaar Remco J.¹,Sidana Surbhi¹,Radivoyevitch Tomas¹,Gerds Aaron T.¹,Carraway Hetty E.¹,Kalaycio Matt¹,Nazha Aziz¹,Adelstein David J.¹,Nasr Christian¹,Maciejewski Jaroslaw P.¹,Majhail Navneed S.¹,Sekeres Mikkael A.¹,Mukherjee Sudipto¹

Affiliation:

1. Remco J. Molenaar, Cleveland Clinic, Cleveland, Ohio, and University of Amsterdam, Amsterdam, the Netherlands; Surbhi Sidana, Cleveland Clinic, Cleveland, Ohio, and Mayo Clinic, Rochester, MN; and Tomas Radivoyevitch, Aaron T. Gerds, Hetty E. Carraway, Matt Kalaycio, Aziz Nazha, David J. Adelstein, Christian Nasr, Jaroslaw P. Maciejewski, Navneed S. Majhail, Mikkael A. Sekeres, and Sudipto Mukherjee, Cleveland Clinic, Cleveland, Ohio

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2018.78.4074

Reference18 articles.

1. Power of Absolute Values to Avoid Data Misinterpretations: The Case of Radioiodine-Induced Leukemia and Myelodysplasia

2. Risk of Hematologic Malignancies After Radioactive Iodine Treatment of Thyroid Cancer: An Unjustified Warning

3. Inconclusive Analysis of the Connection Between Secondary Hematologic Malignancies and Radioiodine Treatment

4. Selective Focus on Rare Hematologic Malignancies Misleads Risk-Benefit Assessment of Radioiodine Therapy of Thyroid Cancer

5. Radioiodine and Its Relationship to Hematologic Malignancy: The Confounding Role of Supraphysiologic Thyroxine

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Papilläre Schilddrüsenkarzinome werden seltener operiert;InFo Hämatologie + Onkologie;2020-05

2. Prognostic Impact of Direct 131I Therapy After Detection of Biochemical Recurrence in Intermediate or High-Risk Differentiated Thyroid Cancer: A Retrospective Cohort Study;Frontiers in Endocrinology;2019-10-29